International Forum on Organoid Research and Biomaterials (IFORBM - 26)

This track focuses on the latest innovations in organoid technology, including novel methods for organoid generation and manipulation. Researchers will present their findings on how these advancements can enhance the fidelity and applicability of organoids in various fields.

This session will explore the use of organoids as models for studying complex diseases, including cancer, neurodegenerative disorders, and infectious diseases. Presentations will highlight how organoids can recapitulate disease pathology and serve as platforms for therapeutic testing.

This track will delve into the role of biomaterials in the cultivation and maintenance of organoids. Discussions will cover the development of novel scaffolds and matrices that support organoid growth and functionality.

This session will examine the potential of organoids in regenerative medicine, focusing on their ability to replace damaged tissues and organs. Researchers will discuss preclinical and clinical applications of organoids in tissue repair and regeneration.

This track will highlight the intersection of stem cell science and organoid research, emphasizing the role of pluripotent and adult stem cells in organoid formation. Presentations will address the mechanisms underlying stem cell differentiation into organoid structures.

This session will focus on the translational aspects of organoid research, including the challenges and opportunities in moving from bench to bedside. Researchers will share insights on how organoids can inform clinical practices and personalized medicine.

This track will explore the use of organoids in drug discovery and development, highlighting their potential to predict drug responses and toxicity. Presentations will cover case studies where organoid models have successfully informed pharmacological strategies.

This session will discuss the emerging clinical applications of organoids in diagnostics and therapeutics. Researchers will present case studies demonstrating how organoids can guide treatment decisions and improve patient outcomes.

This track will address the ethical implications associated with organoid research, including issues related to consent, ownership, and the potential for organoid-derived therapies. Discussions will aim to establish guidelines for responsible research practices.

This session will focus on the role of organoids in advancing personalized medicine, particularly in tailoring treatments to individual patient profiles. Researchers will discuss how organoid models can facilitate the development of patient-specific therapeutic strategies.

This track will explore the future landscape of organoid research, including emerging technologies and interdisciplinary approaches. Participants will discuss potential breakthroughs that could redefine the applications of organoids in health and medicine.